Home › Funds › D. E. Shaw & Co › IMVT
D. E. Shaw & Co position in IMVT
IMMUNOVANT INC · Health Care
Latest position (Q2 2026)1.24M sh
Reported value held$47.80M
Portfolio Weight0.02%
First reportedQ4 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 20.37K | $174.00K | New |
| Q4 2022 | 298.47K | $5.30M | New |
| Q1 2023 | 444.45K | $6.89M | Add |
| Q2 2023 | 763.21K | $14.48M | Add |
| Q3 2023 | 142.56K | $5.47M | Reduce |
| Q4 2023 | 55.97K | $2.36M | Reduce |
| Q1 2024 | 55.91K | $1.81M | Hold |
| Q2 2024 | 41.48K | $1.10M | Reduce |
| Q3 2024 | 62.44K | $1.78M | Add |
| Q4 2024 | 67.67K | $1.68M | Add |
| Q1 2025 | 50.53K | $863.63K | Reduce |
| Q2 2025 | 59.82K | $957.09K | Add |
| Q3 2025 | 56.70K | $914.00K | Reduce |
| Q2 2026 | 1.24M | $47.80M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IMVT
- Fidelity Management & Research (FMR) 16.19M sh · $623.66M · Q2 2026
- BlackRock Inc 7.18M sh · $276.68M · Q2 2026
- Farallon Capital Management 5.80M sh · $223.67M · Q2 2026
- Vanguard Group 7.78M sh · $197.75M · Q4 2025
- Morgan Stanley 4.53M sh · $174.73M · Q2 2026
- Geode Capital Management 2.23M sh · $86.12M · Q2 2026
- Goldman Sachs Group 1.75M sh · $67.47M · Q2 2026
- Bank of America Corp 1.18M sh · $45.52M · Q2 2026
- Northern Trust Corp 794.00K sh · $30.59M · Q2 2026
- Renaissance Technologies 726.80K sh · $28.00M · Q2 2026
- Charles Schwab Investment Management 680.59K sh · $26.22M · Q2 2026